Delivery Order SPE2DB24D9222-SPE2DB26FAZAZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,046.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. This firm fixed-price delivery order, issued on October 16, 2025, with an ultimate completion date of November 6, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, issued on September 26, 2025, with an ultimate completion date of October 20, 2025, carries no set-aside designation, indicating the award was made through full and open competition. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $7,536.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 15, 2025, and was awarded on September 23, 2025. No set-aside designation was utilized for this award, indicating the vendor competed on an unrestricted...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract, awarded on September 24, 2025, carries a ceiling value of $15,063.78 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 16, 2025. This award utilizes no set-aside designation, demonstrating the vendor's competitive...
- The Defense Logistics Agency awarded a $50,212.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $30,127.56 to DMS Pharmaceutical Group Inc. for EXPAREL 266 mg/20 ml vials on September 2, 2025. This firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed in Park Ridge, Illinois. The award carries no set-aside designation, and the product will be supplied to support Department of Defense healthcare operations. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. The order, valued at $1,218.44 with an ultimate completion date of September 24, 2025, was issued on September 3, 2025, under firm fixed-price terms with no set-aside designation. This delivery order is executed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $5,021.26 for EXPAREL 266 mg/20 ml vials. The contract was awarded on July 11, 2025, with an ultimate completion date of August 1, 2025. This delivery order carries no set-aside designation and represents a single-line procurement of the local anesthetic agent EXPAREL to support Department of...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The contract was awarded on August 25, 2025, with a firm fixed-price ceiling value of $6,028.88 and an ultimate completion date of September 16, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a...
- The Defense Logistics Agency awarded a $6,028.88 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. The award, issued on September 19, 2025, with an ultimate completion date of October 10, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA...
- SPE2DB24D9222Indefinite Delivery Contract
- SPE2DB24D9222-SPE2DB26FAZAZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,436.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. The contract is a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and was awarded on October 17, 2025. This award carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. will perform the work at its Park Ridge, Illinois facility. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to supply the Department of Defense's pharmaceutical and medical consumables requirements globally. DMS Pharmaceutical Group's extensive product portfolio, including specialty pharmaceuticals like EXPAREL (a surgical anesthetic), positions the company as a critical supplier within the federal military healthcare supply chain, with documented performance across multiple therapeutic categories supporting DoD medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 10/17/25 |